“Cholestyramine” or “Colestyramine”, Mycotoxins and Mold
The science of mycotoxin detoxification is complex.
National Treatment Centers for Environmental Disease does not subscribe to the use of “Cholestyramine” as a binding agent for removal of mycotoxins from the human body.
Medical and Historical evidence has allowed us to conclude that Cholestyramine is not effective as binding agent in relationship to mycotoxin removal from the human body. There is no clinical evidence, nor any peer review documentation to support such claims.
The theory that all mycotoxins can be bound out of the body is long outdated. The latest research dictates not all mycotoxins can be bound, some must be dissolved, while other must be chemically deactivated
What is the actual clinical purpose for the use of Cholestyramine:
Cholestyramine removes bile acids from the body by forming insoluble complexes with bile acids in the intestine, which are then excreted in the feces. When bile acids are excreted, plasma cholesterol is converted to bile acid to normalize bile acid levels. This conversion of cholesterol into bile acids lowers plasma cholesterol concentrations.
There is no scientific evidence which supports that the clinical use of Cholestyramine actually binds any mycotoxins out of the human body. The historical evidence supports the use of Cholestyramine as an effort to rid the human body of mycotoxins may provide no more than a placebo effect.
National Treatment Centers for Environmental Disease uses a three step method for the removal of mycotoxins from the human body. Our success rate and patient testimonials remain unparalleled throughout the industry.